Check Out What Whales Are Doing With PFE
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bullish stance on Pfizer (NYSE:PFE), with 80% of the investors opening trades with bullish expectations and 20% with bearish. The whale has been targeting a price range from $30.0 to $35.0 for Pfizer over the last 3 months. The price of PFE is currently down -0.96% at $33.66. Cantor Fitzgerald and Truist Securities have downgraded their actions to Overweight and Buy respectively, with price targets of $75 and $62.
September 20, 2023 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Whale investor has taken a bullish stance on Pfizer, targeting a price range of $30-$35. Current price is down -0.96% at $33.66.
The bullish stance of a whale investor, who is targeting a price range of $30-$35, indicates a positive outlook for Pfizer. However, the current price is down, which may be a temporary setback. The downgrades by Cantor Fitzgerald and Truist Securities could also impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100